Key Information Document

This document provides you with key information about this investment product. It is not marketing material. The information is required by law to help you understand the nature, risks, costs, potential gains and losses of this product and to help you

compare it with other products.

TRACKER ON UK DOMESTIC STOCKS BASKET - EUR – OPEN END

ISIN : FREXA0021164 Issuer: Exane Finance | Guarantor: Exane Derivatives | Supervisor: Autorité des Marchés Financiers and Autorité de Contrôle

Prudentiel et de Résolution | Telephone Number: (+33) 1 44 95 70 00 | Website: www.exane.com

KID production date: 30/09/2021

You are about to purchase a product that is not simple and may be difficult to understand.

WHAT IS THIS PRODUCT?

TYPE: Certificate indexed to one or more Underlyings.

OBJECTIVES The Certificate Tracker on UK Domestic Stocks Basket - EUR – Open End issued by Exane Finance carries a risk of capital loss during its life and at maturity.

The Certificate has no maturity date. Starting from the Reference Date, the Holder and/or the Issuer has the option to redeem the Certificate by sending a notice.

The Certificate is denominated in EUR (issue and redemption in EUR). The underlying is denominated in GBP.

The Certificate provides an exposure to a basket of 26 shares

At the Optional Settlement Date, the Holder receives EUR 1,000 multiplied by: - 98.50% (i.e. 100% reduced by the distribution fees of 1.50%) multiplied by the Final Level of the basket of shares expressed as a percentage of its Initial Level, impacted by the currency variations. - Net of the structuring fees (0.80% p.a.)

Where

‒ The Initial Level is the of the Underlying at the close on the Initial Valuation Date.

‒ The Final Level is the of the Underlying at the close on the Valuation Date.

PRODUCT DATA

Initial Valuation Date 22 November 2019 Issue Price EUR 1,000

Issue Date 26 November 2019 Product Currency EUR

Reference Date 22 November 2022

Optional Settlement Date 25 Business Days after sending Valuation Date 20 Business Days after sending

the notice the notice

Type of the underlying Basket of UK Shares

Underlying Tesco (GB0008847096), (GB00B7T77214), (GB0002162385), Plc (GB0004065016), B&M European Value Retail (LU1072616219), Drax (GB00B1VNSX38), Auto Trader Group (GB00BVYVFW23), Barclays plc (GB0031348658), (GB00B4Y7R145), Lloyds Banking Group (GB0008706128), (GB00B033F229), Legal & General (GB0005603997), (GB00B18V8630), Stagecoach (GB00B6YTLS95), (GB0007739609), British Land (GB0001367019), ITV plc (GB0033986497), Severn Trent (GB00B1FH8J72), United Utilities (GB00B39J2M42), Go Ahead Group (GB0003753778), Group (GB00BY9D0Y18), Rightmove (GB00BGDT3G23), St James’s Place (GB0007669376), Next (GB0032089863), Group (GB0007973794), Sainsbury

(GB00B019KW72).

INTENDED RETAIL INVESTOR

This investment is intended for retails investors who:

■ have some knowledge of the financial instrument in question and/or moderate experience of financial markets

■ are able to bear a total loss of capital (up to the total notional amount)

■ have a medium risk tolerance (balanced risk profile)

■ have a short-term investment horizon of more than 1 year and less than 3 years

■ have an objective to invest in a capital growth product

WHAT ARE THE RISKS AND WHAT COULD I GET IN RETURN?

RISK INDICATOR

Exane Solutions | Key Information Document 30 September 2021 1

The risk indicator assumes you keep the product until 22 November 2022. The actual risk can vary significantly if you cash in at an early stage and you may get back less. You may not be able to

cash in early. You may have to pay significant extra costs to cash in early. You may not be able to sell your product easily

or you may have to sell at a price that significantly

impacts on how much you get back.

■ The summary risk indicator is a guide to the level of risk of this product compared to other products. It shows how likely it

is that the product will lose money because of movements in the markets or because we are not able to pay you.

■ We have classified this product as 4 out of 7, which is a medium risk class.

■ This rates the potential losses from future performance at a medium level, and poor market conditions could impact our

capacity to pay you.

■ Be aware of currency risk. You may support a currency risk if you receive the payment in a different currency than your domestic one or if the certificate itself carries a currency risk (i.e. if there is a distinction between the product currency and at least one underlying currency and when the certificate is not currency hedged). This risk is not considered in the

indicator shown above.

■ This product does not include any protection from future market performance so you could lose some or all of your

investment.

■ If we are not able to pay you what is owed, you could lose your entire investment.

■ For detailed information about all risks please refer to the risk sections of the Base Prospectus as specified in the section

“Other relevant information” below.

PERFORMANCE SCENARIOS

Investment [EUR 10,000]

Scenarios 1 year 1.1 years

What might get back after costs EUR 1,873.63 EUR 6,491

Stress scenario

Average return each year -81.26% -30.64%

What might get back after costs EUR 8,278.07 EUR 8,247.65

Unfavourable scenario

Average return each year -17.22% -15.3%

What might get back after costs EUR 10,429.76 EUR 10,544.15

Moderate scenario

Average return each year 4.3% 4.75%

What might get back after costs EUR 13,056.43 EUR 13,397.16

Favourable scenario

Average return each year 30.56% 29.66%

■ This table shows the money you could get back over the next 1.1 years, under different scenarios, assuming that you

invest EUR 10,000.

■ The scenarios shown illustrate how your investment could perform. You can compare them with the scenarios of other

products.

■ The scenarios presented are an estimate of future performance based on evidence from the past on how the value of this investment varies, and are not an exact indicator. What you get will vary depending on how the market performs and

how long you keep the product.

■ The stress scenario shows what you might get back in extreme circumstances and it does not take into account the

situation where we are not able to pay you.

■ The figures shown include all the costs of the product itself, and include the costs of your advisor or distributor. The

figures do not take into account your personal tax situation, which may also affect how much you get back.

WHAT HAPPENS IF THE ISSUER IS UNABLE TO PAY OUT?

If Exane Finance is in default, the holders may enforce the unconditional and irrevocable guarantee given by Exane Derivatives acting as Guarantor. If Exane Derivatives is also in default, the holders may lose some or all of the amounts

invested.

WHAT ARE THE COSTS?

The Reduction in Yield (RIY) shows what impact the total costs you pay will have on the investment return you might get. The

total costs take into account one-off, ongoing and incidental costs. The amounts shown here are the cumulative costs of the product itself, for three different holding periods. They include potential early exit penalties. The figures assume you invest EUR 10,000. The figures are estimates and may change in the

future.

COST OVER TIME The person selling you or advising you about this product may charge you other costs. If so, this person will provide you with

information about these costs, and show you the impact that all costs will have on your investment over time.

Exane Solutions | Key Information Document 30 September 2021 2

Investment [EUR 10,000]

Scenarios If you cash in after 1 year If you cash in after 1.1 years

Total costs EUR 50 EUR 0

Impact on return (RIY) per year 0.5% 0%

COMPOSITION OF COSTS

The table below shows:

‒ The impact each year of the different types of costs on the investment return you might get at the end of the

recommended holding period;

‒ The meaning of the different cost categories.

This table shows the impact on return per year

Entry costs 0% The impact of the costs already included in the price.

One-off costs The impact of the costs taken of exiting your investment

Exit costs 0%

when it matures. The impact of the costs of us buying and selling underlying

Portfolio transaction costs 0%

investments for the product.

Ongoing costs The impact of the costs that we take each year for managing

Other ongoing costs 0%

your investment. The impact of the performance fees. We take these from you

Performance fees 0%

investment if the product outperforms its benchmark. Incidental costs

Carried interests 0% The impact of carried interests.

HOW LONG SHOULD I HOLD IT AND CAN I TAKE MONEY OUT EARLY?

The recommended holding period for the product is until 22 November 2022, which corresponds to the product’s maturity. Under normal market conditions Exane Derivatives plans to contribute an indicative estimate of the market value of the product. You should only take into account the publication of this indicate estimate and you may sell back the product at a

price depending on the prevaling market conditions, which may occur a loss of part or all your invested amount.

HOW CAN I COMPLAIN?

Any complaint can be addressed to your usual contact within Exane Derivatives at the following address:

Exane Derivatives

6 rue Ménars

75002 PARIS

France

e-mail: [email protected] The attention of investors is drawn to the possibility of using the ombudsman in case of unfavorable or partially favorable response to a complaint. Information about the ombudsman and conditions of referral are available on the ombudsman

website: http://www.amf-france.org/en_US/Formulaires-et-declarations/Contact?lst_select_form_theme_id=mediation.

OTHER RELEVANT INFORMATION

The information contained in this Key Information Document does not constitute a recommendation to buy or sell the product

and is no substitute for individual consultation with the investor’s bank or advisor. You can obtain further information about this product from your usual contact. For complete information on the risks involved and on the selling restriction, you should read the Base Prospectus, as may be supplemented, and the relevant Final Terms

which is available on the website of the issuer (www.exane.com/exaneissues). This product may not be offered or sold, directly or indirectly, in the United States of America or to U.S. persons. The term “U.S. person” is defined in Regulation S under the U.S. Securities Act of 1933 (Securities Act). The offering of this product has

not been registered under the Securities Act.

Exane Solutions | Key Information Document 30 September 2021 3